Business Description
CVS Group PLC
ISIN : GB00B2863827
Share Class Description:
CVSGF: Ordinary SharesTotal Employee Number:
8,900Compare
Compare
Traded in other countries / regions
CVSG.UKCVSGF.USA4C9.Germany IPO Date
2017-12-20Description
CVS Group PLC is a veterinary service provider in the United Kingdom. The group operates through three business divisions: Veterinary Practices, Laboratories, Crematoria, and Online Retail Business. The veterinary practice segment generates the majority of the revenues. The company facilitates its veterinary services through its diagnostics, laboratory reports, and pet cremation services. It also offers retail pharmacy through Animed Direct. Geographically, it generates the majority of its revenue from the United Kingdom and also operates in Australia.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.05 | |||||
Equity-to-Asset | 0.41 | |||||
Debt-to-Equity | 0.92 | |||||
Debt-to-EBITDA | 2.46 | |||||
Interest Coverage | 3.31 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 2.99 | |||||
Beneish M-Score | -2.65 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6.6 | |||||
3-Year EBITDA Growth Rate | 7.9 | |||||
3-Year EPS without NRI Growth Rate | -2 | |||||
3-Year FCF Growth Rate | -2.1 | |||||
3-Year Book Growth Rate | 11 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 9.71 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 5.22 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 100 | |||||
9-Day RSI | 100 | |||||
14-Day RSI | 99.66 | |||||
3-1 Month Momentum % | 0.3 | |||||
6-1 Month Momentum % | 2.03 | |||||
12-1 Month Momentum % | -4.89 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.07 | |||||
Quick Ratio | 0.81 | |||||
Cash Ratio | 0.1 | |||||
Days Inventory | 27.82 | |||||
Days Sales Outstanding | 27.87 | |||||
Days Payable | 40.16 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.68 | |||||
Dividend Payout Ratio | 0.1 | |||||
3-Year Dividend Growth Rate | 7.2 | |||||
Forward Dividend Yield % | 0.68 | |||||
5-Year Yield-on-Cost % | 0.68 | |||||
3-Year Average Share Buyback Ratio | -0.3 | |||||
Shareholder Yield % | 6.05 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 43.25 | |||||
Operating Margin % | 6.78 | |||||
Net Margin % | 7.16 | |||||
EBITDA Margin % | 16.01 | |||||
FCF Margin % | 6.85 | |||||
OCF Margin % | 11.89 | |||||
ROE % | 17.38 | |||||
ROA % | 7.05 | |||||
ROIC % | 4.09 | |||||
3-Year ROIIC % | -0.58 | |||||
ROC (Joel Greenblatt) % | 19.97 | |||||
ROCE % | 7.9 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat Score | 5 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 17.14 | |||||
Forward PE Ratio | 12.89 | |||||
PE Ratio without NRI | 14.35 | |||||
Shiller PE Ratio | 38.62 | |||||
Price-to-Owner-Earnings | 7.98 | |||||
PEG Ratio | 1.33 | |||||
PS Ratio | 1.22 | |||||
PB Ratio | 2.83 | |||||
Price-to-Free-Cash-Flow | 17.87 | |||||
Price-to-Operating-Cash-Flow | 10.3 | |||||
EV-to-EBIT | 23.51 | |||||
EV-to-Forward-EBIT | 14.26 | |||||
EV-to-EBITDA | 9.77 | |||||
EV-to-Forward-EBITDA | 7.22 | |||||
EV-to-Revenue | 1.56 | |||||
EV-to-Forward-Revenue | 1.43 | |||||
EV-to-FCF | 22.87 | |||||
Price-to-GF-Value | 0.88 | |||||
Price-to-Projected-FCF | 1.01 | |||||
Price-to-DCF (Earnings Based) | 0.72 | |||||
Price-to-DCF (FCF Based) | 1.13 | |||||
Price-to-Median-PS-Value | 0.54 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.36 | |||||
Earnings Yield (Greenblatt) % | 4.25 | |||||
FCF Yield % | 5.79 | |||||
Forward Rate of Return (Yacktman) % | 16.19 |
CVS Group PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
CVS Group PLC Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| General meeting for 2026 | 2026-11-18 11:00 | In 143 days | ||
| Fourth quarter earnings conference call for 2026 | 2026-10-07 06:00 | In 101 days | ||
| Annual report for 2026 | 2026-10-07 | In 100 days | ||
| Fourth quarter earnings results for 2026 | 2026-10-07 | In 100 days | ||
| Second quarter earnings conference call for 2026 | 2026-02-26 09:30 | 16.22 (+0.00%) | ||
| Second quarter earnings results for 2026 | 2026-02-26 | 16.22 (+0.00%) | ||
| General meeting for 2025 | 2025-11-18 11:00 | 16.58 (+0.00%) | ||
| GBP 0.085000 Cash Dividend | 2025-11-06 | 16.58 (+0.00%) | ||
| Fourth quarter earnings conference call for 2025 | 2025-10-07 06:00 | 16.58 (+0.00%) | ||
| Annual report for 2025 | 2025-10-07 | 16.58 (+0.00%) |
Show
Entries
Guru Commentaries on OTCPK:CVSGF
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on CVS Group PLC
No articles.